Objective Evaluation of the Longevity of A Calcium Hydroxylapatite-Based Filler (Radiesse®)

Journal of Clinical and Cosmetic Dermatology Pub Date : 1900-01-01 DOI:10.16966/2576-2826.163

A. M.

引用次数: 1

Abstract

Background: Calcium hydroxylapatite (CaHA) based soft-tissue filler (Radiesse® , Merz) is categorised as a biodegradable collagen-stimulating implant. It is comprised of a suspension of 25-45 micron diameter microspheres of CaHA(30%) in a carboxymethylcellulose (CMC) gel carrier (70%) and is one of the most well researched soft-tissue fillers. However, great discrepancies exist in the literature regarding the duration of clinical effect with the implant, ranging from only 6 to 24 months.

查看原文本刊更多论文

羟基磷灰石钙基填料(Radiesse®)寿命的客观评价

背景:钙羟基磷灰石(CaHA)为基础的软组织填充物(Radiesse®，Merz)被归类为可生物降解的胶原刺激植入物。它由25-45微米直径的CaHA微球(30%)悬浮在羧甲基纤维素(CMC)凝胶载体(70%)中组成，是研究最充分的软组织填充物之一。然而，文献中关于植入物的临床效果持续时间存在很大差异，从6个月到24个月不等。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Clinical and Cosmetic Dermatology

自引率

0.00%

发文量